The interplay of Fanconi anemia proteins in the DNA damage response

DNA Repair

Volumn 3, Issue 8-9, 2004, Pages 1063-1069

  Wang, Xiaozhe ^a   D'Andrea, Alan D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

BRCA2; FANCD2; Fanconi anemia; Mitomycin C; Monoubiquitination

Indexed keywords

ATM PROTEIN; BRCA2 PROTEIN; BUTADIENE DIEPOXIDE; CISPLATIN; CYCLIN DEPENDENT KINASE; CYCLINE; DNA POLYMERASE; HYDROXYUREA; MITOMYCIN C; NUCLEOPROTEIN; RAD51 PROTEIN; SMALL INTERFERING RNA;

CANCER GROWTH; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CROSS LINKING; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; DNA SYNTHESIS; DOWN REGULATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; FANCONI ANEMIA; GENE DISRUPTION; GENE MUTATION; GENETIC RECOMBINATION; HUMAN; IONIZING RADIATION; METAPHASE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; UBIQUITINATION;

BRCA1 PROTEIN; CELL CYCLE PROTEINS; CHROMATIN; CLONING, MOLECULAR; CROSS-LINKING REAGENTS; DNA; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; GENETIC COMPLEMENTATION TEST; HUMANS; MITOMYCIN; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RECOMBINATION, GENETIC; S PHASE; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 3242887806     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2004.04.005     Document Type: Review

References (41)

1. D'Andrea A.D., Grompe M. The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer. 3(1):2003;23-34
2. Joenje H., Patel K.J. The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet. 2(6):2001;446-457
3. Alter B.P., et al. Cancer in Fanconi anemia. Blood. 101(5):2003;2072
4. Auerbach A.D. Fanconi anemia diagnosis and the diepoxybutane (DEB) test (Editorial). Exp. Hematol. 21(6):1993;731-733
5. Joenje H., et al. Evidence for at least eight Fanconi anemia genes. Am. J. Hum. Genet. 61(4):1997;940-944
6. Levitus M., Rooimans M.A., Steltenpool J., Cool N.F.C., Oostra A.B., Mathew C.G., Hoatlin M.E., Waisfisz Q., Arwert F., de Winter J.P., Joenje H. Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood. 103:2004;2498-2503
7. Hirsch B., et al. Biallelic BRCA2/FANCD1 mutations: association with spontaneous chromosomal instability and solid tumors of childhood. Blood. 103:2004;2544-2549
8. Garcia-Higuera I., et al. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol. Cell Biol. 19(7):1999;4866-4873
9. de Winter J.P., et al. The fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol. Genet. 9(18):2000;2665-2674
10. Meetei A.R., et al. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell Biol. 23(10):2003;3417-3426
11. Meetei A.R., et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35:2003;165-170
12. Garcia-Higuera I., et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell. 7(2):2001;249-262
13. Vanderberg C.J., et al. BRCA1-independent ubiquitination of FANCD2. Mol. Cell. 12(1):2003;247-254
14. X. Wang, P.R. Andreassen, A.D. D'Andrea, Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin, Mol. Cell Biol. 24 (13) (2004) (in press).
15. Howlett N.G., et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 297(5581):2002;606-609
16. Siddique M.A., et al. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells. Exp. Hematol. 29(12):2001;1448-1455
17. Pace P., et al. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 21(13):2002;3414-3423
18. Gordon S.M., Buchwald M. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. Blood. 102(1):2003;136-141
19. Marmorstein L.Y., Ouchi T., Aaronson S.A. The BRCA2 gene product functionally interacts with p53 and RAD51. Proc. Natl. Acad. Sci. U.S.A. 95(23):1998;13869-13874
20. Moynahan M.E., Pierce A.J., Jasin M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell. 7(2):2001;263-272
21. Tutt A., et al. Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J. 20(17):2001;4704-4716
22. Yang H., et al. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science. 297(5588):2002;1837-1848
23. Lomonosov M., et al. Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein. Genes Dev. 17(24):2003;3017-3022
24. Yamamoto K., et al. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol. Cell Biol. 23(15):2003;5421-5430
25. Hussain S., et al. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum. Mol. Genet. 12:2003;2503-2510
26. Brunn D., et al. siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi Anemia cells. DNA Repair. 2:2003;1007-1013
27. Otsuki T., et al. Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. Hum. Mol. Genet. 10(23):2001;2651-2660
28. Taniguchi T., et al. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood. 100(7):2002;2414-2420
29. D'Andrea A.D., Pellman D. Deubiquitinating enzymes: a new class of biological regulators. Crit. Rev. Biochem. Mol. Biol. 33:1998;337-352
30. Akkari Y.M., et al. DNA replication is required To elicit cellular responses to psoralen-induced DNA interstrand cross-links. Mol. Cell Biol. 20(21):2000;8283-8289
31. Taniguchi T., et al. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell. 109(4):2002;459-472
32. Cortez D., et al. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science. 286(5442):1999;1162-1166
33. Gatei M., et al. ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nat. Genet. 25(1):2000;115-119
34. Kim S.T., Xu B., Kastan M.B. Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev. 16(5):2002;560-570
35. Rodriguez M., et al. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. J. Biol. Chem. 278(52):2003;52914-52918
36. Manke I.A., et al. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science. 302(5645):2003;636-639
37. Zou L., Elledge S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science. 300(5625):2003;1542-1548
38. O'Driscoll M., et al. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33(4):2003;497-4501
39. Taniguchi T., et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat. Med. 9(5):2003;568-574
40. Rothfuss A., Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell Biol. 24(1):2004;123-134
41. Nakanishi K., et al. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat. Cell Biol. 4(12):2002;913-920